982
Participants
Start Date
November 26, 2014
Primary Completion Date
March 19, 2018
Study Completion Date
December 31, 2027
Apalutamide
Participants will receive 240 mg (4\*60 mg tablets) of apalutamide once daily orally.
Abiraterone acetate
Participants will receive 1000 mg (4\*250 mg tablets) of abiraterone acetate (AA) once daily orally.
Prednisone
Participants will receive 5 mg tablet of prednisone twice daily orally.
Placebo
Participants will receive matching placebo to apalutamide once daily orally.
Phoenix
La Mesa
Los Angeles
Modesto
San Diego
San Francisco
Santa Barbara
Aurora
Denver
Jensen Beach
Lakeland
New Port Richey
Ocala
Atlanta
Melrose
Niles
Marrero
New Orleans
Shreveport
Auburn
Baltimore
St Louis
Omaha
Las Vegas
Albany
Johnson City
New York
Poughkeepsie
Syracuse
The Bronx
Columbus
Tualatin
Lancaster
Pittsburgh
Charleston
Myrtle Beach
Nashville
Austin
Houston
Norfolk
Richmond
Auburn
Seattle
Spokane
Wenatchee
Madison
Ciudad Automoma Buenos Aires
Ciudad de Buenos Aires
Córdoba
La Rioja
Mendoza
Rosario
Adelaide
Ashford
Camperdown
Herston
Liverpool
Malvern
Melbourne
Southport
Wahroonga
West Heidelberg
Woolloongabba
Antwerp
Brussels
Ghent
Gosselies
Leuven
Liège
Namur
Ottignies
Roeselare
Sint-Niklaas
Barretos
Ijuí
Natal
Porto Alegre
São José do Rio Preto
São Paulo
Abbotsford
Kelowna
Vancouver
Halifax
Barrie
London
Oakville
Toronto
Weston
Montreal
Québec
Sherbrooke
Angers
Caen
Dijon
Le Mans
Lyon
Montpellier
Paris
Saint-Herblain
Toulouse
Berlin
Dresden
Freiburg im Breisgau
Hamburg
Heidelberg
Münster
Nürtingen
Wuppertal
Fukuoka
Kanazawa
Kashiwa
Kita-Gun
Kumamoto
Kurume
Matsuyama
Miyazaki
Nagasaki
Osaka
Ōsaka-sayama
Sakura
Sapporo
Ube
Yokohama
Chihuahua City
Cuernavaca
Culiacán
México
Oaxaca City
Zapopan
Amsterdam
Amsterdam-Zuidoost
Blaricum
Dordrecht
Groningen
Heerlen
Nieuwegein
Nijmegen
Rotterdam
The Hague
Kursk
Moscow
Omsk
Pyatigorsk
Rostov-on-Don
Saint Petersburg
Ufa
Bloemfontein
Cape Town
Johannesburg
Pretoria
Goyang-si
Seongnam
Seoul
Alcorcón
Barcelona
Cadiz
Córdoba
Madrid
San Sebastián de los Reyes
Valencia
Ayr
Belfast
Birmingham
Edinburgh
Glasgow
London
Manchester
Metropolitan Borough of Wirral
Plymouth
Preston
Stevenage
Sutton
Westcliff-on-Sea
Lead Sponsor
Aragon Pharmaceuticals, Inc.
INDUSTRY